Protein kinase Cδ is essential to maintain CIITA gene expression in B cells

Journal of Immunology

Volumn 177, Issue 2, 2006, Pages 950-956

  Kwon, Myung Ja ^a   Soh, Jae Won ^b   Chang, Cheong Hee ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Inha University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; PROTEIN KINASE C DELTA; PROTEIN KINASE C INHIBITOR; SMALL INTERFERING RNA;

ACETYLATION; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CIITA GENE; ENZYME INHIBITION; GENE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; RNA INTERFERENCE; RNA STABILITY; SECOND MESSENGER; TRANSCRIPTION REGULATION;

EID: 33745809179     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.2.950     Document Type: Article

References (49)

1. Mach, B., V. Steimle, E. Martinez-Soria, and W. Reith. 1996. Regulation of MHC class II genes: lessons from a disease. Annu. Rev. Immunol. 14: 301-331.
2. Inaba, K., S. Turley, T. Iyoda, F. Yamaide, S. Shimovama, C. Reise Sours, R. N. Germain, I. Mellman, and R. M. Steinman. 2000. The formation of immunogenic major histocompatibility complex class II-peptide ligands in lysosomal compartments of dendritic cells is regulated by inflammatory stimuli. J. Exp. Med. 191: 927-936.
3. Steinman, R. M., K. Inaba, S. Turley, P. Pierre, and I. Mellman. 1999. Antigen capture, processing, and presentation by dendritic cells: recent cell biological studies. Hum. Immunol. 60: 562-567.
4. O'Keefe, G. M., V. T. Nguyen, L. L. Ping Tang, and E. N. Benveniste. 2001. IFN-γ regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein. J. Immunol. 166: 2260-2269.
5. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81: 4917-4921.
6. Lee, Y. J., R. B. Panek, M. Huston, and E. N. Benveniste. 1995. Role of protein kinase C and tyrosine kinase activity in IFN-γ-induced expression of the class II MHC gene. Am. J. Physiol. 268: C127-C137.
7. Brown, D., M. Paris, M. Hilburger, and B. S. Zwilling. 1994. The induction of persistence of I-A expression by macrophages from Bcgr mice occurs via a protein kinase C-dependent pathway. J. Immunol. 152: 1323-1331.
8. Setterblad, N., I. Onyango, U. Pihlgren, L. Rask, and G. Andersson. 1998. The role of protein kinase C signaling in activated DRA transcription. J. Immunol. 161: 4819-4824.
9. Giroux, M., M. Schmidt, and A. Descoteaux. 2003. IFN-γ-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-α. J. Immunol. 171: 4187-4194.
10. Reith, W., and B. Mach. 2001. The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19: 331-373.
11. Chang, C.-H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178.
12. Harten, J. A., and J. P. Ting. 2000. Class II transactivator: mastering the art of major histocompatibility complex expression. Mol. Cell. Biol. 20: 6185-6194.
13. Masternak, K., A. Muhlethaler-Mottet, J. Villard, M. Zufferey, V. Steimle, and W. Reith. 2000. CIITA is a transcriptional coactivator that is recruited to MHC class II promoters by multiple synergistic interactions with an enhanceosome complex. Genes Dev. 14: 1156-1166.
14. Sisk, T. J., S. Roys, and C.-H. Chang. 2001. Self-association of CIITA and its transactivation potential. Mol. Cell. Biol. 21: 4919-4928.
15. Scholl, T., S. K. Mahanta, and J. L. Strominger. 1997. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc. Natl. Acad. Sci. USA 94: 6330-6334.
16. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75: 135-146.
17. LeibundGut-Landmann, S., J. M. Waldburger, M. Krawczyk, L. A. Otten, T. Suter, A. Fontana, H. Acha-Orbea, and W. Reith. 2004. Mini-review: specificity and expression of CIITA, the master regulator of MHC class II genes. Eur. J. Immunol. 34: 1513-1525.
18. Muhlethaler-Mottet, A., L. A. Otten, V. Steimle, and B. Mac. 1997. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J. 16: 2851-2860.
19. De Lerma Barbara, A., F. A. Procopio, L. Mortara, G. Tosi, and R. S. Accolla. 2005. The MHC class II transactivator (CIITA) mRNA stability is critical for the HLA class II gene expression in myelomonocytic cells. Eur. J. Immunol. 35: 603-611.
20. Grumont, R., P. Lock, M. Mollinari, F. M. Shannon, A. Moore, and S. Gerondakis, 2004. The mitogen-induced increase in T cell size involves PKC and NFAT activation of Rel/NF-κB-dependent c-myc expression. Immunity 21: 19-30.
21. Hinshaw, J. A., C. M. Mueller, D. W. Scott, and M. S. Williams. 2003. B cell receptor signaling mediates immediate protection from Fas-induced apoptosis upstream of caspase activation through an atypical protein kinase C isozyme and de novo protein synthesis. Eur. J. Immunol. 33: 2490-2500.
22. Mancini, A., A. Koch, A. D. Whetton, and T. Tamura. 2004. The M-CSF receptor substrate and interacting protein FMIP is governed in its subcellular localization by protein kinase C-mediated phosphorylation, and thereby potentiates M-CSF-mediated differentiation. Oncogene 23: 6581-6589.
23. Saijo, K., I. Mecklenbrauker, C. Schmedt, and A. Tarakhovsky. 2003. B cell immunity regulated by the protein kinase C family. Ann. NY Acad. Sci. 987: 125-134.
24. Nishizuka, Y. 1992. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science 258: 607-614.
25. Nishizuka, Y. 1995. Protein kinase C and lipid signaling for sustained cellular responses. FASEB J. 9: 484-496.
26. Mischak, H., W. Kolch, J. Goodnight, W. F. Davidson, U. Rapp, S. Rose-John, and J. F. Mushinski. 1991. Expression of protein kinase C genes in hemopoietic cells is cell-type- and B cell-differentiation stage specific. J. Immunol. 147: 3981-3987.
27. Sidorenko, S. P., C. L. Law, S. J. Klaus, K. A. Chandran, M. Takata, T. Kurosaki, and E. A. Clark. 1996. Protein kinase C μ (PKC μ) associates with the B cell antigen receptor complex and regulates lymphocyte signaling. Immunity 5: 353-363.
28. Martin, P., A. Duran, S. Minguet, M. L. Gaspar, M. T. Diaz-Meco, P. Rennert, M. Leitges, and J. Moscat. 2002. Role of ζ PKC in B-cell signaling and function. EMBO J. 21: 4049-4057.
29. Mecklenbrauker, I., K. Saijo, N. Y. Zheng, M. Leitges, and A. Tarakhovsky. 2002. Protein kinase Cδ controls self-antigen-induced B-cell tolerance. Nature 416: 860-865.
30. Blois, J. T., J. M. Mataraza, I. Mecklenbrauker, A. Tarakhovsky, and T. C. Chiles. 2004. Cell receptor-induced cAMP-response element-binding protein activation in B lymphocytes requires novel protein kinase Co. J. Biol. Chem. 279: 30123-30132.
31. Yamamoto, K. K., G. A. Gonzalez, W. H. Biggs III, and M. R. Montminy. 1998. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334: 494-498.
32. Moreno, C. S., G. W. Beresford, P. Louis-Plence, A. C. Morris, and J. M. Boss. 1999. CREB regulates MHC class II expression in a CIITA-dependent manner. Immunity 10: 143-151.
33. Van der Stoep, N., E. Quinten, and P. J. van den Elsen. 2002. Transcriptional regulation of the MHC class II trans-activator (CIITA) promoter III: identification of a novel regulatory region in the 5′-untranslated region and an important role for cAMP-responsive element binding protein 1 and activating transcription factor-1 in CIITA-promoter III transcriptional activation in B lymphocytes. J. Immunol. 169: 5061-5071.
34. Yee, C. S., Y. Yao, Q. Xu, B. McCarthy, D. Sun-Lin, M. Tone, H. Waldmann, and C.-H. Chang. 2005. Enhanced production of IL-10 by dendritic cells deficient in CIITA. J. Immunol. 174: 1222-1229.
35. Soh, J. S., and I. B. Weinstein. 2003. Roles of specific isoforms of protein kinase C in the transcriptional control of cyclin D1 and related genes. J. Biol. Chem. 278: 34709-34716.
36. Sisk, T. J., K. Nickerson, R. P. Kwok, and C.-H. Chang. 2003. Phosphorylation of class II transactivator regulates its interaction ability and transactivation function. Int. Immunol. 15: 1195-1205.
37. Tosi, G., N. Jabrane-Ferrat, and B. M. Peterlin. 2002. Phosphorylation of CIITA directs its oligomerization, accumulation and increased activity on MHCII promoters. EMBO J. 21: 5467-5476.
38. Greer, S. F., J. A. Harton, M. W. Linhoff, C. A. Janczak, J. P. Ting, and D. E. Cressman. 2004. Serine residues 286, 288, and 293 within the CIITA: a mechanism for down-regulating CIITA activity through phosphorylation. J. Immunol. 173: 376-383.
39. Piskurich, J. F., Y. Wang, M. W. Linhoff, L. C. White, and J. P. Ting. 1998. Identification of distinct regions of 5′ flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J. Immunol. 160: 233-240.
40. Cardinaux, J. R., J. C. Notis, Q. Zhang, N. Vo, J. C. Craig, D. M. Pass, R. G. Grennan, and R. H. Goodman. 2000. Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol. Cell. Biol. 20: 1546-1552.
41. Laurance, M. E., R. P. Kwok, M. S. Huang, J. P. Richards, J. R. Lundblad, and R. H. Goodman. 1997. Differential activation of viral and cellular promoters by human T-cell lymphotropic virus-1 tax and cAMP-responsive element modulator isoforms. J. Biol. Chem. 272: 2646-2651.
42. Gourley, T. S., D. R. Patel, K. Nickerson, S.-C. Hong, and C.-H. Chang. 2002. Aberrant expression of Fas ligand in mice deficient for the MHC class II transactivator. J. Immunol. 168: 4414-4419.
43. Chang, C.-H., J. D. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180: 1367-1374.
44. Schnappauf, F., S. B. Hake, M. M. Camacho Carvajal, S. Bontron, B. Lisowska-Grospierre, and V. Steimle. 2003. N-terminal destruction signais lead to rapid degradation of the major histocompatibility complex class II transactivator CIITA. Eur. J. Immunol. 33: 2337-2347.
45. Tjelle, T. E., A. Brech, L. K. Juvet, G. Griffiths, and T. Berg. 1996. Isolation and characterization of early endosomes, late endosomes and terminal lysosomes: their role in protein degradation. J. Cell Sci. 109: 2905-2914.
46. Yuan, L. W., J. W. Soh, and I. B. Weinstein. 2002. Inhibition of histone acetyl-transferase function of p300 by PKC5. Biochim. Biophys. Acta 1592: 205-211.
47. Xie, H., and T. L. Rothstein. 1995. Protein kinase C mediates activation of nuclear cAMP response element-binding protein (CREB) in B lymphocytes stimulated through surface Ig. J. Immunol. 154: 1717-1723.
48. Mayr, B. M., G. Canettieri, and M. R. Montminy. 2001. Distinct effects of cAMP and mitogenic signals on CREB-binding protein recruitment impart specificity to target gene activation via CREB. Proc. Natl. Acad. Sci. USA 98: 10936-10941.
49. Miyamoto, A., K. Nakayama, H. Imaki, S. Hirose, Y. Jiang, M. Abe, T. Tsukiyama, H. Nagahama, S. Ohno, S. Hatakeyama, and K. I. Nakayama. 2002. Increased proliferation of B cells and auto-immunity in mice lacking protein kinase Cδ. Nature 416: 865-869.